Heslop, H E <br/><br/>
Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation.  [electronic resource] 

 -  British journal of haematology  Feb 1991 
 - 237-44 p.  digital 
<br/><br/> Publication Type: Journal Article; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, P.H.S. 
<br/><br/><label>ISSN: </label>0007-1048 
<br/><br/><label>Standard No.: </label>10.1111/j.1365-2141.1991.tb07983.x  doi 
<br/><br/><label>Subjects--Topical Terms: </label><br/>Acute Disease<br/>Adolescent<br/>Adult<br/>Aged<br/>Blood Cell Count<br/>Bone Marrow--pathology<br/>Bone Marrow Transplantation<br/>Female<br/>Granulocyte-Macrophage Colony-Stimulating Factor--biosynthesis<br/>Hematopoietic Cell Growth Factors--blood<br/>Humans<br/>Interleukin-2--therapeutic use<br/>Interleukin-3--biosynthesis<br/>Leukemia, Myeloid--blood<br/>Male<br/>Middle Aged<br/>Multiple Myeloma--blood